Presentations by Event

In Vitro Antibacterial Activity of Sulbactam Durlobactam (ETX2514) against 121 Recent Acinetobacter baumannii Isolates from Patients in India

McLeod SM, Mathur T, Hackel M, Wise M, Morrissey I and Miller AA (IDWeek 2019)

Program(s): durlobactam (etx2514)

In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam (ETX2514) against Pathogenic Burkholderia Species

Miller AA, O'Donnell JP, Lane DJ, Panchal RG and Mueller JP (IDWeek 2019)

Program(s): durlobactam (etx2514)

Resistance to Sulbactam-Durlobactam in Clinical Isolates of Acinetobacter baumannii is Rare and Maps to PBP3

Moussa S, Shapiro AB, McLeod SM and Miller AA (Acinetobacter 2019)

Program(s): durlobactam (etx2514)

Discovery of a Novel Series of Penicillin-binding Protein 3 Inhibitors to Treat Pseudomonas aeruginosa Infections: Rational Design of Biochemical Potency and Bacterial Permeation

Durand-Reville T, Wu X, Guler S, Zhang J, Comita-Prevoir J, Sylvester M, Romero J, Velez-Vega C, Wu F, Iyer R, Shapiro A, Moussa S, Carter N, Chen A, McLeod S, O'Donnell J, Miller A and Tommasi R (ASM ESCMID 2019)